Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK Moves Towards Safe and Effective Electronic Cigarettes and Other NCPs

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
All nicotine-containing products, such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.

The UK Government has decided that the Medicines and Healthcare products Regulatory Agency (MHRA) will regulate all NCPs as medicines so that people using these products have the confidence that they are safe, are of the right quality and work.

Smoking is the biggest single cause of avoidable death - killing 80,000 people in England each year. Making safe and effective products available for people who smoke can help them cut down or quit.

Jeremy Mean, the MHRA’s Group Manager of Vigilance and Risk Management of Medicines, said: "Reducing the harms of smoking to smokers and those around them is a key Government health priority. Our research has shown that existing electronic cigarettes and other nicotine containing products on the market are not good enough to meet this public health priority.

“Some NCPs are already licensed and the Government's decision to work towards medicines licensing for all these products is designed to deliver quality products that will support smokers to cut down and to quit.

“The decision announced today provides a framework that will enable good quality products to be widely available. It’s not about banning products that some people find useful, it’s about making sure that smokers have an effective alternative that they can rely on to meet their needs."

Today’s announcement follows a public consultation on how to regulate these products which demonstrated widespread support for medicines regulation from the public health community.

Scientific and market research into their safety and quality, including how they are used, has underpinned this decision.

People should use licensed NCPs - gums, patches, mouth sprays etc - to reduce the harms of smoking.

Recent public health guidance published by the National Institute for Health and Care Excellence (NICE) supports the use of licensed nicotine products in helping people to cut down or stop smoking.

The quality of NCPs can vary considerably which is why licensing them as medicines will allow people to have the confidence that they are safe, are of the right quality and work.

The UK Government will press for EU law to create a Europe-wide legal position on NCPs as medicines through the revision of the Tobacco Products Directive.

The European Commission has said it expects the new legislation to be adopted in 2014 and for it to come into effect in the UK from 2016. From that point, all NCPs will require a medicine licence. This will allow time for manufacturers to ensure that their products meet the safety, quality and efficacy requirements of a medicine.

Until that law is in place, the MHRA would encourage those manufacturers with unlicensed products currently on the market to apply for a medicine licence.

Chief Medical Officer Professor Dame Sally Davies said: “Smokers are harmed by the deadly tar and toxins in tobacco smoke, not the nicotine.

“While it’s best to quit completely, I realize that not every smoker can and it is much better to get nicotine from safer sources such as nicotine replacement therapy.

“More and more people are using e-cigarettes, so it’s only right these products are properly regulated to be safe and work effectively.”

Deborah Arnott, Chief Executive of health charity ASH, said: “ASH strongly supports the MHRA decision to regulate e-cigarettes and other novel nicotine products - we think this is both proportionate and necessary. Regulation will ensure that e-cigarettes meet the same standards for quality, safety and efficacy as medicines while remaining as readily available to smokers as they are today. Crucially it will also ensure marketing of e-cigarettes and other such products is controlled to prevent their promotion to children and non-smokers.”

Dr Clare Gerada, Chair of the General Council at the Royal College of General Practitioners said: “Rates of smoking in the poorest in our communities remain high, and as a GP in a deprived area of London I see firsthand the deaths and disease this causes. The RCGP supports MHRA regulation of novel nicotine products such as e-cigarettes as this will ensure that they are of good quality and reliability and are effective in helping smokers who want to use them to cut down and quit.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
Man Jailed in Pre-Clinical Trial Data Scam Case
The man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
Friday, April 19, 2013
Warning Over Potentially Toxic Chinese Herbal Medicine
MHRA warn people not to use Zheng Tian Wan to treat migraines.
Thursday, April 18, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
Side Effects to be Discovered more Quickly, Leading to Safer Prescribing
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website www.pharmacopoeia.gov.uk.
Tuesday, September 09, 2008
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!